Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy
- 31 August 2012
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 83 (2), 216-224
- https://doi.org/10.1016/j.critrevonc.2011.10.008
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialThe Lancet Oncology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Discovery and development of sorafenib: a multikinase inhibitor for treating cancerNature Reviews Drug Discovery, 2006
- New therapies for hepatocellular carcinomaOncogene, 2006
- Management of hepatocellular carcinomaHepatology, 2005
- Liver fibrosisJCI Insight, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Hepatocellular carcinomaThe Lancet, 2003